Ranbaxy Laboratories Ltd. Company Profile

08:36 EDT 1st November 2014 | BioPortfolio

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 46 countries and manufacturing operations in 7 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company’s commitment to increase penetration and improve access to medicines, across the globe. For more information, please visit www.ranbaxy.com.


News Articles [525 Associated News Articles listed on BioPortfolio]

Cipher Pharmaceuticals signs distribution agreement with Ranbaxy

MISSISSAUGA, ON- Cipher Pharmaceuticals Inc. announces it has entered into a distribution and supply agreement with Ranbaxy Laboratories Ltd., granting Ranbaxy exclusive rights to market, sell and dis...

India's Ranbaxy Laboratories posts loss in June quarter

MUMBAI, July 29 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd, which has agreed to be acquired by local rival Sun Pharmaceutical Industries Ltd, posted a net loss in the June quarter hit by a ...

Ranbaxy’s manufacturing woes benefit big pharma

Import bans by the US Food and Drug Administration (FDA) on generics from four of Ranbaxy Laboratories’ (Ranbaxy) manufacturing sites have prevented the company from launching new generics, allowing...

Sun To Keep On Ranbaxy Name In Most Global Markets

Sun Pharmaceutical Industries has said that the name of Ranbaxy Laboratories, the company it acquired from Daiichi Sankyo earlier this year, would be retained throughout the world with a few possible ...

India Commission Seeks Comment on Sun-Ranbaxy Deal

An Indian regulatory body has begun accepting comments from the general public and stakeholders that will be affected by the merger of Sun Pharmaceutical Industries and Ranbaxy Laboratories.

BRIEF-Pfizer, Ranbaxy win dismissal of lawsuit by "direct purchaser" plaintiffs over generic Lipitor

Sept 12 (Reuters) - * U.S. judges grants Pfizer Inc Ranbaxy Laboratories Ltd

India's Ranbaxy posts Q2 profit

MUMBAI, Oct 28 (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd, which is in the process of being acquired by larger rival Sun Pharmaceutical Industries Ltd , reported a profit in its sec...

Ranbaxy’s Ohm receives FDA approval for generic of Novartis’ Diovan

Ohm Laboratories, a wholly owned subsidiary of India’s largest drugmaker Ranbaxy Laboratories, has received approval from the US Food and Drug Administration to manufacture and market valsartan, a g...

Drugs and Medications [431 Associated Drugs and Medications listed on BioPortfolio]

Desquam-x wash [Ranbaxy Laboratories Inc.]

DRUG FACTS

Famotidine [Ipca Laboratories Limited]

Famotidine Tablets USP

Cetirizine hydrochloride [Ipca Laboratories Limited]

Cetirizine Hydrochloride Tablets 10 mg

Clindamycin hydrochloride [RedPharm Drug Inc.]

Eurax [Ranbaxy Laboratories Inc.]

Eurax (crotamiton USP)Lotion/Cream (10% w/w)FOR TOPICAL USE ONLYNOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USERx only

PubMed Articles [168 Associated PubMed Articles listed on BioPortfolio]

Completeness and Timeliness of Electronic vs. Conventional Laboratory Reporting for Communicable Disease Surveillance-Oklahoma, 2011.

The Health Information Technology for Economic and Clinical Health (HITECH) Act encourages the meaningful use of certified electronic health record technology. A HITECH-compliant core component is nat...

CardioPluse. Radiation exposure to personnel in cardiac catheterization laboratories: an English summary of a published manuscript where radiation exposure in the cath lab was measured by the lead author Dr Heiner von Bötticher catheterization laboratories.

Impact of Changes in Clostridium difficile Testing Practices on Stool Rejection Policies and C. difficile Positivity Rates across Multiple Laboratories in the United States.

We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium difficile diagnosis and their impact on stool rejection policies and C. difficile positivity rates. Of the laborator...

Implementation of a national external quality assessment program for medical laboratories in burkina faso: challenges, lessons learned, and perspectives.

Objectives: The National External Quality Assessment (NEQA) program of Burkina Faso is a proficiency testing program mandatory for all laboratories in the country since 2006. The program runs two cycl...

Nongynecologic Cytology Practice Patterns: A Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology.

Context.-Nongynecologic cytology (NGC) practices are expected to expand relative to gynecologic cytology. The College of American Pathologists attempts to track practice patterns in NGC using a self-r...

Clinical Trials [179 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following admin...

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

This open-label, balanced, randomized, two-treatment, four-period, two-sequence, single dose, crossover fully replicated study was conducted on fixed-dose combination of quinapril 20 mg an...

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

The objective of this study was to compare the single-dose oral bioavailability of Carvedilol 12.5 mg tablets of Ranbaxy Laboratories with Coreg 12.5 mg tablets of Glaxosmithkline in healt...

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

The objective of this study is to compare the relative bioavailability of glimepiride 1 mg tablets (manufactured by Ranbaxy Laboratories Limited) with that of AMARYL® 1 mg tablets (follow...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [883 Associated Companies listed on BioPortfolio]

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, aff...

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality,...

Sterling Rasayan (P) Ltd

In less than twenty years, Sterling through its professional approach and innovative marketing strategy has been able to cater to the requirements of many prestigious customers from local producers t...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Ranbaxy Laboratories Ltd." on BioPortfolio

We have published hundreds of Ranbaxy Laboratories Ltd. news stories on BioPortfolio along with dozens of Ranbaxy Laboratories Ltd. Clinical Trials and PubMed Articles about Ranbaxy Laboratories Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ranbaxy Laboratories Ltd. Companies in our database. You can also find out about relevant Ranbaxy Laboratories Ltd. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record